Section Review Biologicals & Immunologicals: Progress in the development and patenting of antisense drug discovery technology
- 1 September 1996
- journal article
- Published by Informa Healthcare in Expert Opinion on Therapeutic Patents
- Vol. 6 (9) , 855-870
- https://doi.org/10.1517/13543776.6.9.855
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinaseNature Medicine, 1996
- Antisense Oligonucleotides as Therapeutic Agents—Is the Bullet Really Magical?Science, 1993
- Decapitation of a 5'-capped oligoribonucleotide by o-phenanthroline:copper(II)Journal of the American Chemical Society, 1993
- Therapeutic Applications of OligonucleotidesAnnual Review of Pharmacology and Toxicology, 1992
- Pharmacokinetics, biodistribution, and stability of oligodeoxynucleotide phosphorothioates in mice.Proceedings of the National Academy of Sciences, 1991